Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Keytruda cuts risk of death by 31% in esophageal cancer trial

pharmaphorumJanuary 16, 2019

Tag: Keytruda , esophageal cancer , anti PD-1 therapy , gastrointestinal cancer

PharmaSources Customer Service